View by type:
Articles (4262)
Can mRNA vaccine tech take on tuberculosis?
Clinical trials of an mRNA vaccine for TB are set to begin this year. TB kills around 1.5 million people a year, mostly in developing countries. Research funding remains a major obstacle to progress.
Wanted: A vaccine against the measles
How the measles virus was trapped and tamed in vaccinology’s wild West.
Vaccine reaches Nepal’s provinces just in time for typhoid season
Nepal’s government has kicked off a major typhoid conjugate vaccine (TCV) campaign, also introducing this lifesaving vaccine into the country’s routine immunisation programme.
People who’ve had COVID appear more likely to develop diabetes – here’s why that might be
A number of recent studies indicate people who have had COVID are more likely to be diagnosed with diabetes.
Stopping cholera before it can start: vaccines reach South Sudan’s flood-hit IDP camps
To pre-empt potential cholera outbreaks due to flooding, Unity State in South Sudan has vaccinated 200,000 people.
Tackling Cameroon’s worst cholera outbreak in decades
Health experts in Cameroon have called for vigilance and the respect of basic hygienic rules as the country grapples with a severe cholera outbreak.
WHO says just one dose of HPV vaccine protects against cervical cancer
Cervical cancer kills one woman every two minutes, but the need for two or three doses is a major reason why vaccine uptake has been slow – this finding should mean many more lives are saved through HPV vaccination.
Everything you need to know about COVID-19 antivirals
Several antiviral pills have now been authorised to treat COVID-19, but how do they work and will people in developing countries be able to access them?
India draws lessons from polio eradication initiative
The programme to eradicate polio shows that mass immunisation is possible in India.
Celebrating Nepal’s typhoid conjugate vaccine introduction
The introduction of typhoid conjugate vaccine in Nepal is a great step forward in keeping children healthy and protected from typhoid.
Europe at risk of measles resurgence as COVID-19 restrictions are eased
With many countries failing to hit measles vaccine coverage targets, and COVID-19 control measures being lifted, the goal of measles elimination hangs in the balance.
World leaders commit US$ 4.8 billion to help Break COVID Now
Summit sees US$ 4.8 billion in commitments, securing vital cash to help lower income countries boost vaccinations now, secure equitable access for new vaccine procurements plus additional help for countries looking to procure their own vaccines…